DONG Rui-fang, XIA Yuan-zheng, KONG Ling-yi. The technologies of small molecule ligand-target protein interaction and high throughput ligand screeningJ. Acta Pharmaceutica Sinica, 2023, 58(11): 3242-3253. DOI: 10.16438/j.0513-4870.2023-0649
Citation: DONG Rui-fang, XIA Yuan-zheng, KONG Ling-yi. The technologies of small molecule ligand-target protein interaction and high throughput ligand screeningJ. Acta Pharmaceutica Sinica, 2023, 58(11): 3242-3253. DOI: 10.16438/j.0513-4870.2023-0649

The technologies of small molecule ligand-target protein interaction and high throughput ligand screening

  • The interaction of drug and target protein is a critical part of new drug discovery. It is the premise for drugs to exert therapeutic effects by targeting specific binding sites of target proteins and thereby affecting its pharmacological activity. Currently, a variety of techniques are exploited to detect the interaction between drug ligands and target proteins. For example, cellular thermal shift assay (CETSA) and differential scanning fluorimetry (DSF) based on thermodynamics, mass spectrometry and nuclear magnetic resonance technology, etc. In addition, high-throughput ligand screening technology provides technical convenience for the search of specific ligand, and is a powerful tool to efficiently identify the interaction between drug ligand and target protein. Here, we summarize the detection techniques of interaction between small molecules and target proteins, and discuss the application of high-throughput ligand screening technology in drug research.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return